Literature DB >> 24802390

Resveratrol reduces the proinflammatory effects and lipopolysaccharide- induced expression of HMGB1 and TLR4 in RAW264.7 cells.

Ying Yang1, Shuping Li, Qiao Yang, Yu Shi, Min Zheng, Yanning Liu, Feng Chen, Guangzhong Song, Hangdi Xu, Tianhong Wan, Jiliang He, Zhi Chen.   

Abstract

BACKGROUND: Resveratrol (Res) is a polyphenol anti-inflammatory agent. We have studied the link between the anti-inflammatory effects of Res and the high mobility group box 1(HMGB1) signaling pathway.
METHODS: Murine macrophage-like RAW264.7 cells (RAW264.7 cells) were either untreated (control) or treated with Res, LPS, or LPS + Res. Levels of IL-6, NO, and TNF-α were measured by ELISA and colorimetric assays. Expression of HMGB1 was detected by qRT-PCR, western blot, and immunofluorescence assays. Protein and mRNA expression levels of TLR4 were also examined.
RESULTS: Res significantly reduced the levels of IL-6, NO, and TNF-α in RAW264.7 cells exposed to LPS. Expression levels of HMGB1 (mRNA and protein) and of TLR4 in the LPS + Res-treated cells were lower than in cells treated with LPS alone.
CONCLUSIONS: Res can block the inflammatory effects induced by LPS in RAW264.7 cells. Down-regulation of HMGB expression may be one of the mechanisms of action of Res. Res may also influence TLR4 expression in the HMGB1-TLR4 signaling pathway.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24802390     DOI: 10.1159/000358696

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  14 in total

1.  Chikusetsusaponin V Inhibits LPS-Activated Inflammatory Responses via SIRT1/NF-κB Signaling Pathway in RAW264.7 Cells.

Authors:  Qin Yuan; Dengqing Zhang; Chaoqi Liu; Changcheng Zhang; Ding Yuan
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

2.  Resveratrol attenuates lipopolysaccharide-induced acute kidney injury by suppressing inflammation driven by macrophages.

Authors:  Liang Chen; Sixing Yang; Elizabeth E Zumbrun; Hongbing Guan; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Mol Nutr Food Res       Date:  2015-03-18       Impact factor: 5.914

3.  Resveratrol Downregulates Biomarkers of Sepsis Via Inhibition of Proteasome's Proteases.

Authors:  Neerupma Silswal; Nidhi S Reddy; Asaf A Qureshi; Nilofer Qureshi
Journal:  Shock       Date:  2018-11       Impact factor: 3.454

4.  Reduced HMGB 1-Mediated Pathway and Oxidative Stress in Resveratrol-Treated Diabetic Mice: A Possible Mechanism of Cardioprotection of Resveratrol in Diabetes Mellitus.

Authors:  Han Wu; Zhen-Qiang Sheng; Jun Xie; Ran Li; Liang Chen; Guan-Nan Li; Lian Wang; Biao Xu
Journal:  Oxid Med Cell Longev       Date:  2016-10-19       Impact factor: 6.543

5.  Antioxidant and Anti-Inflammatory Effects of Herbal Formula SC-E3 in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages.

Authors:  Soo Chil Lee; Young-Won Kwon; Ju-Yeon Park; Sung Yun Park; Ju-Hee Lee; Sun-Dong Park
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-15       Impact factor: 2.629

Review 6.  Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

Authors:  Ulf Andersson; William Ottestad; Kevin J Tracey
Journal:  Mol Med       Date:  2020-05-07       Impact factor: 6.354

Review 7.  Phenolic Compounds Exerting Lipid-Regulatory, Anti-Inflammatory and Epigenetic Effects as Complementary Treatments in Cardiovascular Diseases.

Authors:  Laura Toma; Gabriela Maria Sanda; Loredan Stefan Niculescu; Mariana Deleanu; Anca Volumnia Sima; Camelia Sorina Stancu
Journal:  Biomolecules       Date:  2020-04-21

8.  In vitro inhibition effects of hepatitis B virus by dandelion and taraxasterol.

Authors:  Ying Yang; Gaoxiang Ying; Shanshan Wu; Fengtian Wu; Zhi Chen
Journal:  Infect Agent Cancer       Date:  2020-07-06       Impact factor: 2.965

9.  Resveratrol Attenuates Acute Inflammatory Injury in Experimental Subarachnoid Hemorrhage in Rats via Inhibition of TLR4 Pathway.

Authors:  Xiang-Sheng Zhang; Wei Li; Qi Wu; Ling-Yun Wu; Zhen-Nan Ye; Jing-Peng Liu; Zong Zhuang; Meng-Liang Zhou; Xin Zhang; Chun-Hua Hang
Journal:  Int J Mol Sci       Date:  2016-08-12       Impact factor: 5.923

Review 10.  Targeting Inflammation Driven by HMGB1.

Authors:  Huan Yang; Haichao Wang; Ulf Andersson
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.